prostate-report.org

Long-term use of cholesterol-lowering statin drugs raise the risk of prostate cancer among obese men

According to findings of a new study published in in the American Journal of Epidemiology, use of cholesterol-lowering statin drugs, especially long-term use, appears to raise the risk of prostate cancer among obese men.

Among obese men, current use of a statin was associated with a 50 percent increase in risk of prostate cancer; and use for 5 or more years was associated with an 80 percent increase in risk of the disease; both of these risk estimates were statistically significant.

The research team from Fred Hutchinson Cancer Research Center in Seattle, suggests that these findings warrant further investigation.